LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 186 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $249,000 | -79.2% | 3,425 | -61.2% | 0.00% | -75.0% |
| Q4 2018 | $1,198,000 | +385.0% | 8,825 | +880.6% | 0.01% | +700.0% |
| Q3 2018 | $247,000 | -32.7% | 900 | -87.0% | 0.00% | -66.7% |
| Q4 2014 | $367,000 | -34.9% | 6,900 | -42.5% | 0.00% | -40.0% |
| Q3 2014 | $564,000 | -50.6% | 12,000 | -30.2% | 0.01% | -37.5% |
| Q2 2014 | $1,141,000 | -68.9% | 17,200 | -65.2% | 0.01% | -70.4% |
| Q1 2014 | $3,668,000 | – | 49,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |